Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print December 6, 2006, doi:10.1212/01.wnl.0000251269.31442.d9)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000251269.31442.d9v1
68/8/569    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osborne, R. J.
Right arrow Articles by Tawil, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osborne, R. J.
Right arrow Articles by Tawil, R.
Received June 30, 2006
Accepted October 16, 2006

Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy

R. J. Osborne PhD, S. Welle PhD, S. L. Venance MD, PhD, C. A. Thornton MD, and R. Tawil MD*

From the Departments of Neurology (R.J.O., C.A.T., R.T.), and Medicine (S.W.), University of Rochester School of Medicine and Dentistry, Rochester, NY; and the Department of Clinical Neurological Sciences (S.L.V.), London Health Sciences Centre, London, ON, Canada.


* To whom correspondence should be addressed. E-mail: rabi_tawil{at}urmc.rochester.edu.

Abstract-- Background: Facioscapulohumeral muscular dystrophy (FSHD) is caused by deletions within a tandem array of D4Z4 repeats on chromosome 4q35. In addition to muscle degeneration, most patients with FSHD develop abnormalities of the retinal vasculature. Previous work has suggested that muscle degeneration in FSHD results from increased expression of genes proximal to the deletion, including FRG1. Objectives: To reexamine this mechanism and identify pathways that are abnormally regulated early in the disease process. Methods: We prospectively studied gene expression in skeletal muscle in patients with FSHD (n = 19) vs healthy individuals (n = 30) and patients with myotonic dystrophy type 1 (n = 12). We used oligonucleotide microarrays for global analysis of gene expression and reverse transcriptase-PCR (RT-PCR) to assess expression or alternative splicing for particular genes. Results: Expression of FRG1 was not increased in patients with FSHD, either by microarray analysis or quantitative RT-PCR. Among genes on 4q35, only LRP2BP showed upregulation that was specific to FSHD. However, neither LRP2BP nor FRG1 showed imbalance of allelic expression by RT-PCR. After filtering out genes that showed similar dysregulation in other forms of muscular dystrophy, only 44 genes were specifically upregulated early in FSHD. Among these, 34 genes were characterized or partially characterized, of which 11 (32%) had a role in vascular smooth muscle or endothelial cells. Conclusion: Expression of genes on chromosome 4q35 was normally regulated in the early stages of facioscapulohumeral muscular dystrophy. Our results support a possible link between muscular dystrophy and retinal vasculopathy in facioscapulohumeral muscular dystrophy.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
X. Xu, K. Tsumagari, J. Sowden, R. Tawil, A. P. Boyle, L. Song, T. S. Furey, G. E. Crawford, and M. Ehrlich
DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q35.2
Nucleic Acids Res., October 9, 2009; (2009) gkp833v1.
[Abstract] [Full Text] [PDF]

Home page
 DMMHome page
R. D. Wuebbles, M. L. Hanel, and P. L. Jones
FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy
Dis. Model. Mech., May 1, 2009; 2(5-6): 267 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Arashiro, I. Eisenberg, A. T. Kho, A. M. P. Cerqueira, M. Canovas, H. C. A. Silva, R. C. M. Pavanello, S. Verjovski-Almeida, L. M. Kunkel, and M. Zatz
Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers
PNAS, April 14, 2009; 106(15): 6220 - 6225.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
L Davidovic, S Sacconi, E G Bechara, S Delplace, M Allegra, C Desnuelle, and B Bardoni
Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients
J. Med. Genet., October 1, 2008; 45(10): 679 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Tsumagari, L. Qi, K. Jackson, C. Shao, M. Lacey, J. Sowden, R. Tawil, V. Vedanarayanan, and M. Ehrlich
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers
Nucleic Acids Res., April 1, 2008; 36(7): 2196 - 2207.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi, H. Qian, S. Sauvage, C. Matteotti, A. M. van Acker, O. Leo, et al.
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1
PNAS, November 13, 2007; 104(46): 18157 - 18162.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. A. Greenberg and G. W. Padberg
Pushing the genetic frontier with facioscapulohumeral muscular dystrophy
Neurology, February 20, 2007; 68(8): 544 - 545.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by AAN Enterprises, Inc.